Skip to main content

People in the News: Feb 3, 2009

Premium

Frank Witney has been named chief commercial officer at Affymetrix. As CCO, Witney is charged with integrating the commercial teams of Affy and its recently acquired companies, Panomics, True Materials, and USB.

Witney joined Panomics, formerly Genospectra, as CEO in 2002. Prior to that, he served as president of drug discovery tools at PerkinElmer Life sciences.

Witney was a postdoc fellow at the National Institutes of Health and holds a PhD in molecular and cell biology from Indiana University.


Allen Bombard has accepted the job of chief medical officer at Sequenom. In the role, Bombard will oversee the company's clinical and medical affairs.

Formerly, Bombard was CEO at Lenetix, chief medical officer at Sharp Mary Birch Hospital in San Diego, and he was senior vice president and director of the residency program in obstetrics and gynecology at Lutheran Medical Center in Brooklyn, NY. He also has served as a medical director for women's health at Aetna, and he was director of the Department of Obstetrics and Gynecology and Women's Health at Montefiore Medical Center and the Albert Einstein College of Medicine in Bronx, NY.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.